Dose Dependent Effects on Cell Cycle Checkpoints and DNA Repair by Bendamustine

Bendamustine (BDM) is an active chemotherapeutic agent approved in the U. S. for treating chronic lymphocytic leukemia and non-Hodgkin lymphoma. Its chemical structure suggests it may have alkylator and anti-metabolite activities; however the precise mechanism of action is not well understood. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Beeharry, Neil, Rattner, Jerome B., Bellacosa, Alfonso, Smith, Mitchell R., Yen, Timothy J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386996/
https://www.ncbi.nlm.nih.gov/pubmed/22768280
http://dx.doi.org/10.1371/journal.pone.0040342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386996/
https://www.ncbi.nlm.nih.gov/pubmed/22768280
http://dx.doi.org/10.1371/journal.pone.0040342

Ejemplares similares